208 related articles for article (PubMed ID: 36051340)
1. Role of gadoxetic acid-enhanced liver magnetic resonance imaging in the evaluation of hepatocellular carcinoma after locoregional treatment.
Gatti M; Maino C; Darvizeh F; Serafini A; Tricarico E; Guarneri A; Inchingolo R; Ippolito D; Ricardi U; Fonio P; Faletti R
World J Gastroenterol; 2022 Jul; 28(26):3116-3131. PubMed ID: 36051340
[TBL] [Abstract][Full Text] [Related]
2. Performance of gadoxetic acid MRI and diffusion-weighted imaging for the diagnosis of early recurrence of hepatocellular carcinoma.
Rimola J; Forner A; Sapena V; Llarch N; Darnell A; Díaz A; García-Criado A; Bianchi L; Vilana R; Díaz-González Á; Ayuso C; Bruix J; Reig M
Eur Radiol; 2020 Jan; 30(1):186-194. PubMed ID: 31372783
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic performance of gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced multi-detector computed tomography in detecting hepatocellular carcinoma: a meta-analysis of eight prospective studies.
Li J; Wang J; Lei L; Yuan G; He S
Eur Radiol; 2019 Dec; 29(12):6519-6528. PubMed ID: 31250172
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic accuracy of MRI with extracellular vs. hepatobiliary contrast material for detection of residual hepatocellular carcinoma after locoregional treatment.
Rimola J; Davenport MS; Liu PS; Brown T; Marrero JA; McKenna BJ; Hussain HK
Abdom Radiol (NY); 2019 Feb; 44(2):549-558. PubMed ID: 30218239
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of Hepatocellular Carcinoma Using Gd-EOB-DTPA MR Imaging.
Murakami T; Sofue K; Hori M
Magn Reson Med Sci; 2022 Mar; 21(1):168-181. PubMed ID: 34421091
[TBL] [Abstract][Full Text] [Related]
6. Intra-individual comparison of hepatocellular carcinoma imaging features on contrast-enhanced computed tomography, gadopentetate dimeglumine-enhanced MRI, and gadoxetic acid-enhanced MRI.
Kim YN; Song JS; Moon WS; Hwang HP; Kim YK
Acta Radiol; 2018 Jun; 59(6):639-648. PubMed ID: 28825310
[TBL] [Abstract][Full Text] [Related]
7. Gadoxetic acid disodium-enhanced magnetic resonance imaging outperformed multidetector computed tomography in diagnosing small hepatocellular carcinoma: A meta-analysis.
Liu X; Jiang H; Chen J; Zhou Y; Huang Z; Song B
Liver Transpl; 2017 Dec; 23(12):1505-1518. PubMed ID: 28886231
[TBL] [Abstract][Full Text] [Related]
8. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic performance of contrast-enhanced multidetector computed tomography and gadoxetic acid disodium-enhanced magnetic resonance imaging in detecting hepatocellular carcinoma: direct comparison and a meta-analysis.
Guo J; Seo Y; Ren S; Hong S; Lee D; Kim S; Jiang Y
Abdom Radiol (NY); 2016 Oct; 41(10):1960-72. PubMed ID: 27318936
[TBL] [Abstract][Full Text] [Related]
10. Combined Application of Gadoxetic Acid Disodium-Enhanced Magnetic Resonance Imaging (MRI) and Diffusion-Weighted Imaging (DWI) in the Diagnosis of Chronic Liver Disease-Induced Hepatocellular Carcinoma: A Meta-Analysis.
Li X; Li C; Wang R; Ren J; Yang J; Zhang Y
PLoS One; 2015; 10(12):e0144247. PubMed ID: 26629904
[TBL] [Abstract][Full Text] [Related]
11. Gd-EOB-DTPA-enhanced MRI is better than MDCT in decision making of curative treatment for hepatocellular carcinoma.
Yoo SH; Choi JY; Jang JW; Bae SH; Yoon SK; Kim DG; Yoo YK; Rha SE; Lee YJ; Jung ES
Ann Surg Oncol; 2013 Sep; 20(9):2893-900. PubMed ID: 23649931
[TBL] [Abstract][Full Text] [Related]
12. Clinical usefulness of the ablative margin assessed by magnetic resonance imaging with Gd-EOB-DTPA for radiofrequency ablation of hepatocellular carcinoma.
Koda M; Tokunaga S; Okamoto T; Hodozuka M; Miyoshi K; Kishina M; Fujise Y; Kato J; Matono T; Sugihara T; Oyama K; Hosho K; Okano J; Murawaki Y; Kakite S; Yamashita E
J Hepatol; 2015 Dec; 63(6):1360-7. PubMed ID: 26232269
[TBL] [Abstract][Full Text] [Related]
13. Health economic evaluation of Gd-EOB-DTPA MRI vs ECCM-MRI and multi-detector computed tomography in patients with suspected hepatocellular carcinoma in Thailand and South Korea.
Lee JM; Kim MJ; Phongkitkarun S; Sobhonslidsuk A; Holtorf AP; Rinde H; Bergmann K
J Med Econ; 2016 Aug; 19(8):759-68. PubMed ID: 27026278
[TBL] [Abstract][Full Text] [Related]
14. Impact of gadoxetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance on the non-invasive diagnosis of small hepatocellular carcinoma: a prospective study.
Granito A; Galassi M; Piscaglia F; Romanini L; Lucidi V; Renzulli M; Borghi A; Grazioli L; Golfieri R; Bolondi L
Aliment Pharmacol Ther; 2013 Feb; 37(3):355-63. PubMed ID: 23199022
[TBL] [Abstract][Full Text] [Related]
15. Application of Gd-EOB-DTPA-enhanced magnetic resonance imaging (MRI) in hepatocellular carcinoma.
Li XQ; Wang X; Zhao DW; Sun J; Liu JJ; Lin DD; Yang G; Liu H; Xia ZY; Jia CY; Li HJ
World J Surg Oncol; 2020 Aug; 18(1):219. PubMed ID: 32828123
[TBL] [Abstract][Full Text] [Related]
16. Hepatobiliary-phase gadolinium ethoxybenzyl-diethylenetriaminepentaacetic acid MRI for pretreatment prediction of efficacy-to-standard-therapies based on Barcelona Clinic Liver Cancer algorithm: an up-to-date review.
Minamiguchi K; Irizato M; Uchiyama T; Taiji R; Nishiofuku H; Marugami N; Tanaka T
Eur Radiol; 2023 Dec; 33(12):8764-8775. PubMed ID: 37470828
[TBL] [Abstract][Full Text] [Related]
17. Value of Gd-EOB-DTPA-Enhanced MRI and Diffusion-Weighted Imaging in Detecting Residual Hepatocellular Carcinoma After Drug-Eluting Bead Transarterial Chemoembolization.
Liu HF; Xu YS; Liu Z; Che KY; Sheng Y; Ding JL; Zhang JG; Lei JQ; Xing W
Acad Radiol; 2021 Jun; 28(6):790-798. PubMed ID: 32414638
[TBL] [Abstract][Full Text] [Related]
18. Hepatocellular carcinoma detection in liver cirrhosis: diagnostic performance of contrast-enhanced CT vs. MRI with extracellular contrast vs. gadoxetic acid.
Semaan S; Vietti Violi N; Lewis S; Chatterji M; Song C; Besa C; Babb JS; Fiel MI; Schwartz M; Thung S; Sirlin CB; Taouli B
Eur Radiol; 2020 Feb; 30(2):1020-1030. PubMed ID: 31673837
[TBL] [Abstract][Full Text] [Related]
19. Arterial subtraction images of gadoxetate-enhanced MRI improve diagnosis of early-stage hepatocellular carcinoma.
Kim DH; Choi SH; Byun JH; Kang JH; Lim YS; Lee SJ; Kim SY; Won HJ; Shin YM; Kim PN
J Hepatol; 2019 Sep; 71(3):534-542. PubMed ID: 31108157
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of combined Gd-EOB-DTPA and gadobutrol magnetic resonance imaging for the prediction of hepatocellular carcinoma grading.
Schelhorn J; Best J; Dechêne A; Göbel T; Bertram S; Lauenstein T; Kinner S
Acta Radiol; 2016 Aug; 57(8):932-8. PubMed ID: 26586852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
